MLTX logo

MLTX Selling, General & Administrative Expenses

Annual SGA

$30.32 M
+$8.00 M+35.83%

December 31, 2024


Summary


Performance

MLTX SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherMLTXexpensesmetrics:

Quarterly SGA

$9.22 M
+$1.84 M+25.00%

December 31, 2024


Summary


Performance

MLTX Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherMLTXexpensesmetrics:

TTM SGA

-$710.51 M
-$118.94 M-20.10%

December 31, 2024


Summary


Performance

MLTX TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherMLTXexpensesmetrics:

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

MLTX Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+35.8%+25.0%-2634.8%
3 y3 years-+67.2%-3210.6%
5 y5 years-+67.2%-3210.6%

MLTX Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+35.8%at high+105.7%-1224.5%at low
5 y5-yearat high+35.8%at high+227.6%-1224.5%at low
alltimeall timeat high+35.8%at high+227.6%-1224.5%at low

MoonLake Immunotherapeutics Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Dec 2024
$30.32 M(+35.8%)
$9.22 M(+25.0%)
$30.32 M(+8.2%)
Sep 2024
-
$7.38 M(+6.7%)
$28.03 M(+7.6%)
Jun 2024
-
$6.92 M(+1.6%)
$26.05 M(+10.3%)
Mar 2024
-
$6.81 M(-1.8%)
$23.61 M(+5.8%)
Dec 2023
$22.32 M
$6.93 M(+28.6%)
$22.32 M(+7.7%)
Sep 2023
-
$5.39 M(+20.3%)
$20.72 M(-1.7%)
Jun 2023
-
$4.48 M(-18.8%)
$21.07 M(-7.7%)
DateAnnualQuarterlyTTM
Mar 2023
-
$5.52 M(+3.6%)
$22.84 M(+0.1%)
Dec 2022
$23.01 M
$5.33 M(-7.3%)
$22.81 M(+30.5%)
Sep 2022
-
$5.75 M(-8.1%)
$17.49 M(+0.9%)
Jun 2022
-
$6.25 M(+13.9%)
$17.34 M(+24.7%)
Mar 2022
-
$5.49 M(-2.0%)
$13.90 M(+65.2%)
Sep 2021
-
$5.60 M(+98.9%)
$8.41 M(+198.9%)
Jun 2021
-
$2.81 M
$2.81 M

FAQ

  • What is MoonLake Immunotherapeutics annual SGA?
  • What is the all time high annual SGA for MoonLake Immunotherapeutics?
  • What is MoonLake Immunotherapeutics annual SGA year-on-year change?
  • What is MoonLake Immunotherapeutics quarterly SGA?
  • What is the all time high quarterly SGA for MoonLake Immunotherapeutics?
  • What is MoonLake Immunotherapeutics quarterly SGA year-on-year change?
  • What is MoonLake Immunotherapeutics TTM SGA?
  • What is the all time high TTM SGA for MoonLake Immunotherapeutics?
  • What is MoonLake Immunotherapeutics TTM SGA year-on-year change?

What is MoonLake Immunotherapeutics annual SGA?

The current annual SGA of MLTX is $30.32 M

What is the all time high annual SGA for MoonLake Immunotherapeutics?

MoonLake Immunotherapeutics all-time high annual SGA is $30.32 M

What is MoonLake Immunotherapeutics annual SGA year-on-year change?

Over the past year, MLTX annual SGA has changed by +$8.00 M (+35.83%)

What is MoonLake Immunotherapeutics quarterly SGA?

The current quarterly SGA of MLTX is $9.22 M

What is the all time high quarterly SGA for MoonLake Immunotherapeutics?

MoonLake Immunotherapeutics all-time high quarterly SGA is $9.22 M

What is MoonLake Immunotherapeutics quarterly SGA year-on-year change?

Over the past year, MLTX quarterly SGA has changed by +$1.84 M (+25.00%)

What is MoonLake Immunotherapeutics TTM SGA?

The current TTM SGA of MLTX is -$710.51 M

What is the all time high TTM SGA for MoonLake Immunotherapeutics?

MoonLake Immunotherapeutics all-time high TTM SGA is -$53.64 M

What is MoonLake Immunotherapeutics TTM SGA year-on-year change?

Over the past year, MLTX TTM SGA has changed by -$738.54 M (-2634.81%)